3,509 results match your criteria: "University Hospital Hamburg-Eppendorf[Affiliation]"
NMR Biomed
January 2025
Physikalisch-Technische Bundesanstalt (PTB), Braunschweig und Berlin, Berlin, Germany.
To improve reliability of metabolite quantification at both, 3 T and 7 T, we propose a novel parametrized macromolecules quantification model (PRaMM) for brain H MRS, in which the ratios of macromolecule peak intensities are used as soft constraints. Full- and metabolite-nulled spectra were acquired in three different brain regions with different ratios of grey and white matter from six healthy volunteers, at both 3 T and 7 T. Metabolite-nulled spectra were used to identify highly correlated macromolecular signal contributions and estimate the ratios of their intensities.
View Article and Find Full Text PDFHeart
December 2024
University Center for Cardiovascular Science & Department of Cardiology, University Heart and Vascular Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Clin Gastroenterol Hepatol
December 2024
Health Services Research, Durham University, Durham, United Kingdom.
Background And Aims: Budesonide orodispersible tablets (BOT) have been shown to be safe and effective in phase 3 double-blind trials of induction and 48-week maintenance therapy of eosinophilic esophagitis (EoE). We now analyzed the long-term efficacy and safety of BOT in a 96-week open-label extension (OLE) study.
Methods: All EoE patients in the 48-week double-blind maintenance study were eligible to receive BOT treatment for up to 96 weeks.
Cells
December 2024
Biochemistry and Tumor Biology Lab, Department of Obstetrics and Gynecology, Hannover Medical School, 30625 Hannover, Germany.
Pancreatic ductal adenocarcinoma (PDAC) has an extremely poor prognosis, due in part to early invasion and metastasis, which in turn involves epithelial-mesenchymal transition (EMT) of the cancer cells. Prompted by the discovery that two PDAC cell lines of the quasi-mesenchymal subtype (PANC-1, MIA PaCa-2) exhibit neuroendocrine differentiation (NED), we asked whether NED is associated with EMT. Using real-time PCR and immunoblotting, we initially verified endogenous expressions of various NED markers, i.
View Article and Find Full Text PDFInnov Surg Sci
December 2024
Orthopädische Klinik, Stiftung Herzogin Elisabeth Hospital (HEH), Braunschweig, Germany.
Periprosthetic joint infections (PJIs) are dramatic complications after primary total joint arthroplasty. Despite increasing research in this field, the diagnosis, classification, and management of PJI remain a challenge. This is mainly due to the heterogenous clinical presentation of PJI in clinical routine and patient-related factors as secondary diagnosis and periprosthetic tissue condition.
View Article and Find Full Text PDFJBMR Plus
January 2025
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, 63010, Germany.
Hormonal agents administered for metastatic castration-resistant prostate cancer (mCRPC) may lead to osteoporosis, skeletal events, reduced quality of life, and even reduced overall survival (OS). Bone-modifying agents may prevent those events but their effect on cancer-control outcomes remains uncertain. Relying on our institutional tertiary-care database, we explored the effect of bone-modifying agents (bisphosphonates such as zoledronic acid and denosumab) on OS and progression-free survival in patients with mCRPC with at least 1 bone metastasis using Kaplan-Meyer estimates and Cox regression models.
View Article and Find Full Text PDFAnn Surg
December 2024
Department of General, Visceral and Thoracic Surgery, University Hospital Hamburg Eppendorf, Hamburg, Germany.
Objective: To describe the evolution of management strategies for neuroendocrine liver metastases (NE LM) and trends in patient outcomes over the preceding 3 decades.
Summary Background Data: Liver metastases are common in neuroendocrine neoplasms and impair prognosis. A broad therapeutic armamentarium has evolved over recent decades but there remains uncertainty regarding optimal treatment selection and sequencing.
BJU Int
December 2024
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Objectives: It is not known whether cancer-specific mortality (CSM) differences distinguish radical cystectomy (RC) from trimodal therapy (TMT) in octogenarians harbouring organ-confined (T2N0M0) urothelial cancer of the urinary bladder (UCUB).
Methods: Within the Surveillance, Epidemiology, and End Results database (2004-2021), CSM and other-cause mortality (OCM) rates were computed in octogenarian patients with organ-confined UCUB undergoing either TMT or RC. Smoothed cumulative incidence plots depicted 5-year CSM and OCM rates according to RC vs TMT.
N Engl J Med
December 2024
From the Department of Obstetrics and Gynecology, University of Rostock, Rostock, Germany (T.R., A.S., B.G.); University Hospital Ulm, Ulm, Germany (K.V., I.B.); Hospital Esslingen, Esslingen, Germany (T.K.); University Hospital Heidelberg, Heidelberg, Germany (J. Heil, M.G.); the Breast Unit, Sankt Elisabeth Hospital, Heidelberg, Germany (J. Heil, M.G.); Evang. Waldkrankenhaus Spandau, Berlin (S.P.); the Faculty of Medicine Mannheim, Department of Obstetrics and Gynecology, University of Heidelberg, Mannheim, Germany (F.M.); the Department of Obstetrics and Gynecology, Hanau City Hospital, Hanau, Germany (T.M.); the Department of Radiation Oncology, University Hospital Rostock, Rostock, Germany (G.H.); the Department of Radiotherapy and Radiation Oncology, University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany (D.K.); the Department of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany (D.K.); Medical School and University Medical Center OWL, Department of Gynecology and Obstetrics, Bielefeld University, Klinikum Lippe, Detmold, Germany (B.A.); Salzburg Regional Hospital, Salzburg, Austria (R.R.); Johanniter-Hospital Genthin-Stendal, Genthin, Germany (S.R.); the Institute of Pathology, Philipps-University Marburg and University Hospital Marburg (UKGM), Marburg, Germany (C.D.); Breast Center St. Gallen, Kantonsspital, St. Gallen, Switzerland (I.B.); SRH Wald-Klinikum Gera, Gera, Germany (D.-M.Z.); the Department of Gynecology and Gynecologic Oncology, Agaplesion Markus Hospital, Frankfurt am Main, Germany (M.T.); the German Breast Group, Neu-Isenburg, Germany (J. Holtschmidt, V.N., S.L.); and the Tumor and Breast Center Eastern Switzerland, St. Gallen, Switzerland (M.K.).
Background: Whether surgical axillary staging as part of breast-conserving therapy can be omitted without compromising survival has remained unclear.
Methods: In this prospective, randomized, noninferiority trial, we investigated the omission of axillary surgery as compared with sentinel-lymph-node biopsy in patients with clinically node-negative invasive breast cancer staged as T1 or T2 (tumor size, ≤5 cm) who were scheduled to undergo breast-conserving surgery. We report here the per-protocol analysis of invasive disease-free survival (the primary efficacy outcome).
Klin Padiatr
December 2024
Institute for Medical Psychology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Background: Early detection of psychological problems is crucial to prevent chronic progression. The Psych-U study evaluated the added value of structured assessment of psychological issues during U-screenings compared to routine screenings without such assessment.
Methods: In a cluster-randomized controlled design, a two-arm intervention group (IG; Strengths and Difficulties Questionnaire, SDQ, and Mannheimer Elternfragebogen, MEF) was compared to a control group (CG).
Ann Surg Oncol
December 2024
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, QC, Canada.
Objective: This study aimed to compare adverse in-hospital outcomes in ileal conduit versus neobladder urinary diversion type after radical cystectomy (RC) in contemporary versus historical patients.
Methods: Patients were identified within the National Inpatient Sample (NIS 2000-2019). Propensity score matching (PSM; 1:2 ratio) and multivariable logistic regression models (LRMs) were used.
Eur Urol Focus
December 2024
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany. Electronic address:
JCO Precis Oncol
December 2024
Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany.
J Clin Oncol
December 2024
Champalimaud Foundation, Lisbon, Portugal.
BJPsych Open
December 2024
University Hospital of Child and Adolescent Psychiatry and Psychotherapy Bern, University of Bern, Switzerland.
Aesthetic Plast Surg
December 2024
Department of Plastic Surgery, Jiangsu Province Hospital of Chinese Medicine, Nanjing, 210001, Jiangsu Province, China.
World J Urol
December 2024
Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Genome Biol
December 2024
Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, 72076, Germany.
J Clin Med
November 2024
University Heart and Vascular Center Hamburg, Department for Vascular Medicine, University Hospital Hamburg-Eppendorf, 20251 Hamburg, Germany.
Long-term gender-specific survival and cancer incidence in patients with ruptured abdominal aortic aneurysm (rAAA) were investigated after endovascular (EVAR) and open repair (OAR). : Data from 2933 patients (EVAR n = 1187, OAR n = 1746) from a health insurance company in Germany (men n = 2391, women n = 542) were analyzed. All patients were cancer-free in their history.
View Article and Find Full Text PDFHealthcare (Basel)
November 2024
BioMarin International Ltd., London WC1A 2SL, UK.
J Stomatol Oral Maxillofac Surg
November 2024
Department of Oral and Maxillofacial Surgery, Klinikum Dortmund and Witten/Herdecke University, Dortmund/ Witten, Germany.
Hemasphere
November 2024
Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.
World J Urol
November 2024
Martini-Klinik Prostate Cancer Centre, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Purpose: The aim of our study was to investigate the impact of the time interval between prostate biopsy and radical prostatectomy (RP) on postoperative urinary continence (UC)/erectile function (EF). From a clinical point of view, an interval of several weeks seems to facilitate surgical preparation.
Materials And Methods: We retrospectively analyzed patients who underwent RP for localized prostate cancer (PCa) in a tertiary care center between 2011 and 2020.
Psychiatr Danub
August 2024
Dept. of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg, Germany.